346 related articles for article (PubMed ID: 30690664)
1. Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.
Woerman AL; Oehler A; Kazmi SA; Lee J; Halliday GM; Middleton LT; Gentleman SM; Mordes DA; Spina S; Grinberg LT; Olson SH; Prusiner SB
Acta Neuropathol; 2019 Mar; 137(3):437-454. PubMed ID: 30690664
[TBL] [Abstract][Full Text] [Related]
2. Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synuclein.
Holec SAM; Lee J; Oehler A; Ooi FK; Mordes DA; Olson SH; Prusiner SB; Woerman AL
Acta Neuropathol; 2022 Oct; 144(4):677-690. PubMed ID: 36018376
[TBL] [Abstract][Full Text] [Related]
3. Transmission of multiple system atrophy prions to transgenic mice.
Watts JC; Giles K; Oehler A; Middleton L; Dexter DT; Gentleman SM; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19555-60. PubMed ID: 24218576
[TBL] [Abstract][Full Text] [Related]
4. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5308-17. PubMed ID: 26324905
[TBL] [Abstract][Full Text] [Related]
5. MSA prions exhibit remarkable stability and resistance to inactivation.
Woerman AL; Kazmi SA; Patel S; Freyman Y; Oehler A; Aoyagi A; Mordes DA; Halliday GM; Middleton LT; Gentleman SM; Olson SH; Prusiner SB
Acta Neuropathol; 2018 Jan; 135(1):49-63. PubMed ID: 28849371
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.
Woerman AL; Patel S; Kazmi SA; Oehler A; Lee J; Mordes DA; Olson SH; Prusiner SB
PLoS Pathog; 2020 Feb; 16(2):e1008222. PubMed ID: 32017806
[TBL] [Abstract][Full Text] [Related]
7. Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
Krejciova Z; Carlson GA; Giles K; Prusiner SB
Acta Neuropathol Commun; 2019 May; 7(1):81. PubMed ID: 31109379
[TBL] [Abstract][Full Text] [Related]
8. Is Multiple System Atrophy a Prion-like Disorder?
Jellinger KA; Wenning GK; Stefanova N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255
[TBL] [Abstract][Full Text] [Related]
9. Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.
Woerman AL; Kazmi SA; Patel S; Aoyagi A; Oehler A; Widjaja K; Mordes DA; Olson SH; Prusiner SB
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):409-414. PubMed ID: 29279394
[TBL] [Abstract][Full Text] [Related]
10. The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.
Lau HHC; Martinez-Valbuena I; So RWL; Mehra S; Silver NRG; Mao A; Stuart E; Schmitt-Ulms C; Hyman BT; Ingelsson M; Kovacs GG; Watts JC
Acta Neuropathol Commun; 2023 May; 11(1):72. PubMed ID: 37138318
[TBL] [Abstract][Full Text] [Related]
11. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
[TBL] [Abstract][Full Text] [Related]
12. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
[TBL] [Abstract][Full Text] [Related]
13. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated α-synuclein.
Mougenot AL; Bencsik A; Nicot S; Vulin J; Morignat E; Verchère J; Bétemps D; Lakhdar L; Legastelois S; Baron TG
J Neuropathol Exp Neurol; 2011 May; 70(5):377-85. PubMed ID: 21487306
[TBL] [Abstract][Full Text] [Related]
14. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402
[TBL] [Abstract][Full Text] [Related]
15. The E46K mutation modulates α-synuclein prion replication in transgenic mice.
Holec SAM; Lee J; Oehler A; Batia L; Wiggins-Gamble A; Lau J; Ooi FK; Merz GE; Wang M; Mordes DA; Olson SH; Woerman AL
PLoS Pathog; 2022 Dec; 18(12):e1010956. PubMed ID: 36454879
[TBL] [Abstract][Full Text] [Related]
16. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
[TBL] [Abstract][Full Text] [Related]
17. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
19. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.
Thomzig A; Wagenführ K; Pinder P; Joncic M; Schulz-Schaeffer WJ; Beekes M
Acta Neuropathol; 2021 Jun; 141(6):861-879. PubMed ID: 33895878
[TBL] [Abstract][Full Text] [Related]
20. Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.
Okuda S; Uemura N; Sawamura M; Taguchi T; Ikuno M; Uemura MT; Yamakado H; Takahashi R
Neurotherapeutics; 2022 Jan; 19(1):289-304. PubMed ID: 34935120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
